Nitric Oxide Synthesis and Function Vasodilators, such as acetylcholine, bradykinin, and adenosine do not exert their effects upon the vascular smooth muscle cells in the absence of the overlying endothelium
The first one, the EMPA-REG OUTCOME trial, investigated in 7020 T2DM patients with overt cardiovascular disease the effect of empagliflozin on a primary combined endpoint of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke [1]
Articles were carefully read, and data related to disease models, DPP4i dose, treatment duration, and main findings as well as the underlying molecular mechanisms were summarized in a tabular form
This reads as one medical group referred to by two slightly different names across the brand's own materials, likely a collective trade reference ("Arora Health Group") versus the full registered legal entity name ("Arora Health & Aesthetics, LLC"), rather than two separate organizations